CR Sanjiu Medical & Pharmaceutical Company Limited, a subsidiary of China Resources Pharmaceutical Group Ltd., focuses on the manufacturing and sales of pharmaceutical products and health-related services. As an indirect non-wholly owned subsidiary, CR Sanjiu is 63.02% owned by China Resources Pharmaceutical Group Ltd. The company is listed on the Shenzhen Stock Exchange under the stock code 000999. Through its comprehensive operations, CR Sanjiu continues to play a significant role within the Group's core business, which includes research and development, manufacturing, distribution, and retail of pharmaceutical and healthcare products.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief on May 14, 2025, and is solely responsible for the information contained therein.